Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass

Contraception

Volumn 79, Issue 2, 2009, Pages 117-121

  Uras, Roberto ^a   Orrù, Marisa ^a   Etzi, Rossella ^a   Peppi, Giangavino ^a   Marotto, Maria Francesca ^a   Pilloni, Monica ^a   Zedda, Pierina ^a   Lello, Stefano ^a   Melis, Gian Benedetto ^a   Paoletti, Anna Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Body composition; Chlormadinone acetate; Fat mass; Multifrequency bioelectrical impedance; Oral contraceptives

Indexed keywords

CHLORMADINONE ACETATE; CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY WATER; BODY WEIGHT; CONTROLLED STUDY; ELECTROLYTE BLOOD LEVEL; EXTRACELLULAR FLUID; FEMALE; FOLLICULAR PHASE; HUMAN; INTRACELLULAR FLUID; MENSTRUAL CYCLE; MULTIFREQUENCY BIOELECTRICAL IMPEDANCE ANALYSIS; MULTIPLE CYCLE TREATMENT; ORAL CONTRACEPTION; WAIST HIP RATIO;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; BODY WATER; BODY WEIGHT; CHLORMADINONE ACETATE; CONTRACEPTIVES, ORAL, COMBINED; ELECTRIC IMPEDANCE; ETHINYL ESTRADIOL; FEMALE; HUMANS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 58149174096     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.08.007     Document Type: Article

References (25)

1. Walters W.A.W., and Lim Y.L. Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaecol Br Commonw 77 (1970) 1088-1099
2. Crane M.G., and Harris J.J. Effect of oestrogens and gestagens on exchangeable sodium. In: Fregly M.J., and Fregly M.S. (Eds). Oral contraceptives and high blood pressure (1974), Dolphin Press, Gainesville (FL) 159-169
3. Oelkers W.K. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61 (1996) 166-171
4. Cagnacci A., Zanin R., Cannoletta M., Generali M., Caretto S., and Volpe A. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. Fertil Steril 88 (2007) 1603-1608
5. Cagnacci A., De Toni A., Caretto S., et al. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. Menopause 13 (2006) 197-201
6. Poehlman E.T. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 81 (2002) 603-611
7. Arciero P.J., Goran M.I., and Poehlman E.T. Resting metabolic rate is lower in women than in men. J Appl Physiol 75 (1993) 2514-2520
8. Buchholz A.C., Rafii M., and Pencharz P.B. Is resting metabolic rate different between men and women?. Br J Nutr 86 (2001) 641-646
9. Rosenberg M.J., and Waugh M.S. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 (1998) 577-582
10. Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Contraception 58 (1998) 345-349
11. Gallo M.F., Grimes D.A., Schulz K.F., and Helmerhorst F.M. Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials. Obstet Gynecol 103 (2004) 359-373
12. Kyle U.G., Bosaeus I., De Lorenzo A.D., et al. Bioelectrical impedance analysis - part II: utilization in clinical practice. Clin Nutr 23 (2004) 1430-1453
13. Martinoli R., Mohamed E.I., Maiolo C., et al. Total body fluid estimation using bioelectrical impedance: a meta-analysis of the data available in the literature. Acta Diabetol 40 Suppl 1 (2003) S203`-S206`
14. Gudivaka R., Schoeller D.A., Kushner R.F., and Bolt M.J. Single and multifrequency model for bioelectrical impedance analysis of body water compartments. J Appl Physiol 87 (1999) 1087-1096
15. Curran M.P., and Wagstaff A.J. Ethinylestradiol/chlormadinone acetate. Drugs 64 (2004) 751-760
16. Schindler A.E., Campagnoli C., Druckmann R., et al. Classification and pharmacology of progestins. Maturitas 46 Suppl 1 (2003) S7-S16
17. Raudrant D., and Rabe T. Progestogens with antiandrogenic properties. Drugs 63 (2003) 463-492
18. Fruzzetti F., Lello S., Lazzarini V., et al. The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular fluid occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study. Contraception 75 (2007) 199-203
19. Lello S., Vittori G., Paoletti A.M., Sorge R., Guardianelli F., and Melis G.B. Effects on body weight and body composition of a low-dose oral estroprogestin containing ethinyl estradiol 20 microg plus levonorgestrel 100 microg. Gynecol Endocrinol 23 (2007) 632-637
20. Thomas L., and Krebs C.J. A review of statistical power analysis software Vol. 78 (1997), Bulletin of the Ecological Society of America, New York 128-139
21. Reubinoff B.E., Grubstein A., Meirow D., Berry E., Schenker J.G., and Brzezinski A. Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertil Steril 63 (1995) 516-521
22. de Melo N.R., Aldrighi J.M., Faggion Jr. D., et al. A prospective open-label study to evaluate the effects of the oral contraceptive Harmonet (gestodene75/EE20) on body fat. Contraception 70 (2004) 65-71
23. Machado R.B., Tachotti F., Cavenague G., and Maia E. Effects of two different oral contraceptives on total body water: a randomized study. Contraception 73 (2006) 344-347
24. Hu F.B., Manson J.E., Stampfer M.J., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345 (2001) 790-797
25. Key T.J., Appleby P.N., Reeves G.K., et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95 (2003) 1218-1226